Madico Guillermo, Ngampasutadol Jutamas, Gulati Sunita, Vogel Ulrich, Rice Peter A, Ram Sanjay
Evans Biomedical Research Center, Boston University Medical Center, Boston, MA 02118, USA.
J Immunol. 2007 Apr 1;178(7):4489-97. doi: 10.4049/jimmunol.178.7.4489.
Neisseria gonorrhoeae and Neisseria meningitidis both express the lacto-N-neotetraose (LNT) lipooligosaccharide (LOS) molecule that can be sialylated. Although gonococcal LNT LOS sialylation enhances binding of the alternative pathway complement inhibitor factor H and renders otherwise serum-sensitive bacteria resistant to complement-dependent killing, the role of LOS sialylation in meningococcal serum resistance is less clear. We show that only gonococcal, but not meningococcal, LNT LOS sialylation enhanced factor H binding. Replacing the porin (Por) B molecule of a meningococcal strain (LOS sialylated) that did not bind factor H with gonococcal Por1B augmented factor H binding. Capsule expression did not alter factor H binding to meningococci that express gonococcal Por. Conversely, replacing gonococcal Por1B with meningococcal PorB abrogated factor H binding despite LNT LOS sialylation. Gonococcal Por1B introduced in the background of an unsialylated meningococcus itself bound small amounts of factor H, suggesting a direct factor H-Por1B interaction. Factor H binding to unsialylated meningococci transfected with gonococcal Por1B was similar to the sialylated counterpart only in the presence of higher (20 microg/ml) concentrations of factor H and decreased in a dose-responsive manner by approximately 80% at 1.25 microg/ml. Factor H binding to the sialylated strain remained unchanged over this factor H concentration range however, suggesting that LOS sialylation facilitated optimal factor H-Por1B interactions. The functional counterpart of factor H binding showed that sialylated meningococcal mutants that possessed gonococcal Por1B were resistant to complement-mediated killing by normal human serum. Our data highlight the different mechanisms used by these two related species to evade complement.
淋病奈瑟菌和脑膜炎奈瑟菌都表达可被唾液酸化的乳糖 - N - 新四糖(LNT)脂寡糖(LOS)分子。虽然淋球菌LNT LOS的唾液酸化增强了替代途径补体抑制剂H因子的结合,并使原本对血清敏感的细菌对补体依赖性杀伤产生抗性,但LOS唾液酸化在脑膜炎球菌血清抗性中的作用尚不清楚。我们发现只有淋球菌而非脑膜炎球菌的LNT LOS唾液酸化增强了H因子的结合。用淋球菌Por1B替换不结合H因子的脑膜炎球菌菌株(LOS已唾液酸化)的孔蛋白(Por)B分子,可增强H因子的结合。荚膜表达并未改变H因子与表达淋球菌Por的脑膜炎球菌的结合。相反,尽管LNT LOS已唾液酸化,但用脑膜炎球菌PorB替换淋球菌Por1B会消除H因子的结合。在未唾液酸化的脑膜炎球菌背景中引入的淋球菌Por1B本身可结合少量H因子,提示H因子与Por1B之间存在直接相互作用。仅在较高(20μg/ml)浓度的H因子存在时,H因子与转染了淋球菌Por1B的未唾液酸化脑膜炎球菌的结合才与唾液酸化的对应物相似,并且在1.25μg/ml时以剂量反应方式降低约80%。然而,在该H因子浓度范围内,H因子与唾液酸化菌株的结合保持不变,这表明LOS唾液酸化促进了最佳的H因子 - Por1B相互作用。H因子结合的功能对应物表明,具有淋球菌Por1B的唾液酸化脑膜炎球菌突变体对正常人血清介导的补体杀伤具有抗性。我们的数据突出了这两个相关菌种用于逃避补体的不同机制。